Martin Götte Selected Research

Martin Götte Research Topics

Disease

52	Neoplasms (Cancer) 05/2022 - 01/2006
42	Breast Neoplasms (Breast Cancer) 10/2022 - 04/2005
14	Inflammation (Inflammations) 05/2022 - 04/2002
14	Endometriosis 03/2022 - 03/2013
10	Neoplasm Metastasis (Metastasis) 05/2022 - 09/2006
10	Carcinogenesis 01/2021 - 01/2007
8	Carcinoma (Carcinomatosis) 01/2022 - 01/2006
8	Triple Negative Breast Neoplasms 01/2022 - 01/2013
8	Inflammatory Breast Neoplasms 01/2021 - 01/2017
5	Hypersensitivity (Allergy) 01/2020 - 04/2009
4	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 07/2021
4	Wounds and Injuries (Trauma) 01/2021 - 10/2004
3	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 10/2011
3	Pathologic Processes 01/2021 - 11/2004
3	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 04/2008 - 02/2005
2	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2022 - 01/2007
2	Necrosis 03/2022 - 01/2021
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 07/2021
2	Disease Progression 07/2021 - 11/2014
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 05/2020
2	Cysts 10/2020 - 01/2013
2	Brain Neoplasms (Brain Tumor) 05/2020 - 01/2019
2	Colitis 01/2017 - 01/2010
1	Serous Cystadenocarcinoma 05/2022
1	Hodgkin Disease (Hodgkin's Disease) 07/2021
1	Chronic Disease (Chronic Diseases) 01/2021

Drug/Important Bio-Agent (IBA)

28	Syndecan-1 (Syndecan 1)IBA 10/2022 - 04/2002
16	MicroRNAs (MicroRNA)IBA 10/2021 - 09/2012
14	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 05/2022 - 10/2004
13	Small Interfering RNA (siRNA)IBA 12/2022 - 09/2012
11	Proteoglycans (Proteoglycan)IBA 10/2022 - 01/2007
11	Biomarkers (Surrogate Marker)IBA 07/2021 - 07/2014
11	Heparitin Sulfate (Heparan Sulfate)IBA 01/2021 - 04/2003
10	Messenger RNA (mRNA)IBA 12/2022 - 04/2005
8	Proteins (Proteins, Gene)FDA Link 10/2021 - 07/2014
7	Hyaluronic Acid (Hyaluronan)IBA 12/2022 - 11/2006
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2021 - 10/2004
7	ChemokinesIBA 05/2021 - 04/2002
6	CytokinesIBA 05/2022 - 04/2009
6	EnzymesIBA 10/2021 - 11/2006
6	GlycosaminoglycansIBA 09/2020 - 11/2004
5	Cadherins (E-Cadherin)IBA 10/2022 - 01/2007
5	Estrogens (Estrogen)FDA Link 01/2022 - 07/2014
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 07/2014
5	Estrogen ReceptorsIBA 01/2022 - 06/2009
5	heparanaseIBA 07/2021 - 11/2006
5	IntegrinsIBA 01/2017 - 04/2002
5	DecorinIBA 05/2013 - 02/2005
4	Peptide Hydrolases (Proteases)FDA Link 05/2022 - 10/2004
4	Hormones (Hormone)IBA 11/2021 - 01/2013
4	Indicators and Reagents (Reagents)IBA 10/2021 - 09/2012
4	Syndecan-4IBA 10/2021 - 07/2007
4	LigandsIBA 05/2021 - 09/2006
4	Pharmaceutical PreparationsIBA 05/2020 - 02/2015
4	Biological ProductsIBA 12/2017 - 09/2006
3	SyndecansIBA 05/2022 - 04/2003
3	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2022 - 03/2020
3	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2018
3	CollagenIBA 01/2021 - 07/2006
3	Estradiol (Delestrogen)FDA LinkGeneric 12/2017 - 04/2005
3	Protein Isoforms (Isoforms)IBA 12/2017 - 02/2015
3	Endothelin A ReceptorIBA 09/2010 - 04/2005
3	Endothelins (Endothelin)IBA 08/2010 - 04/2005
2	Syndecan-3IBA 05/2022 - 12/2009
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 08/2010
2	ResveratrolIBA 01/2022 - 01/2021
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021 - 05/2013
2	SulfotransferasesIBA 01/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2015
2	Transforming Growth Factor beta (TGF-beta)IBA 10/2020 - 01/2019
2	Estrogen Receptor betaIBA 12/2017 - 06/2009
2	Estrogen Receptor alphaIBA 12/2017 - 06/2009
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2017 - 01/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 05/2013
2	Dextrans (Dextran)FDA Link 01/2017 - 01/2010
2	OxazoloneIBA 12/2011 - 04/2009
2	Fulvestrant (Faslodex)FDA Link 09/2010 - 06/2009
2	Aromatase InhibitorsIBA 09/2010 - 06/2009
2	Endothelin-1 (Endothelin 1)IBA 09/2010 - 12/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 08/2005
2	xylosylprotein 4-beta-galactosyltransferaseIBA 04/2008 - 07/2006
2	BiglycanIBA 07/2006 - 08/2005
1	Hyaluronan SynthasesIBA 12/2022
1	rho-Associated KinasesIBA 10/2022
1	Extracellular Matrix ProteinsIBA 05/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2022
1	Cyclin-Dependent Kinase Inhibitor p21IBA 03/2022
1	EndometIBA 03/2022
1	Aurora Kinase AIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Growth Factor ReceptorsIBA 01/2022
1	GlypicansIBA 07/2021
1	Thromboplastin (Tissue Factor)IBA 05/2021
1	Zoledronic Acid (Zometa)FDA Link 01/2021
1	4-hydroxybenzyl alcoholIBA 01/2021

Therapy/Procedure

20	Therapeutics 01/2022 - 12/2007
8	Drug Therapy (Chemotherapy) 05/2022 - 01/2006
2	Neoadjuvant Therapy 07/2014 - 01/2006